Solasia Pharma KK
TSE:4597
Solasia Pharma KK
TSE:4597
Price:
27 JPY
Market Closed
Updated:
May 14, 2024
Solasia Pharma KK
Selling, General & Administrative
|
Solasia Pharma KK
Selling, General & Administrative Peer Comparison
Comparables:
2160
4587
4974
J
7774
S
4599
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Solasia Pharma KK
TSE:4597
|
Selling, General & Administrative
-¥1.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Selling, General & Administrative
-¥14.6B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-34%
|
|
|
PeptiDream Inc
TSE:4587
|
Selling, General & Administrative
-¥7.3B
|
CAGR 3-Years
-93%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Selling, General & Administrative
-¥16.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Selling, General & Administrative
-¥1.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
|
S
|
StemRIM Inc
TSE:4599
|
Selling, General & Administrative
-¥608.9m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Selling, General & Administrative?
Selling, General & Administrative
-1.1B
JPY
-1.1B
JPY
Based on the financial report for Dec 31, 2023, Solasia Pharma KK's Selling, General & Administrative amounts to -1.1B JPY.
What is Solasia Pharma KK's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
0%
0%
Over the last year, the Selling, General & Administrative growth was 39%. The average annual Selling, General & Administrative growth rates for Solasia Pharma KK have been 3% over the past three years .
You don't have any saved screeners yet
